May 11, 2021
Chugai Pharmaceutical said on May 10 that it has agreed with the Japanese government to secure this year’s domestic supply for its COVID-19 antibody cocktail, which was originated by Regeneron Pharmaceuticals, if approved. The antibody cocktail pairing casirivimab and imdevimab,...read more